Published in Tex Heart Inst J on October 01, 2015
Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation. Dig Dis Sci (2016) 0.75
The coagulopathy of chronic liver disease. N Engl J Med (2011) 5.63
A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02
Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol (2012) 2.97
Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion (2005) 2.76
Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci (1981) 2.36
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl (2005) 2.35
A randomized comparison of transradial versus transfemoral approach for coronary angiography and angioplasty. JACC Cardiovasc Interv (2009) 2.34
Performance standards for therapeutic abdominal paracentesis. Hepatology (2004) 1.93
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology (2014) 1.91
Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl (2005) 1.67
An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology (2009) 1.54
Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol (2009) 1.53
Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion (2003) 1.48
Safety of transradial cardiac catheterization in patients with end-stage liver disease. Catheter Cardiovasc Interv (2013) 1.47
Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology (2005) 1.27
FVIII production by human lung microvascular endothelial cells. Blood (2006) 1.19
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology (2001) 1.11
Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology (2002) 1.02
Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology (2003) 0.93
Cardiac catheterization in patients with end-stage liver disease: safety and outcomes. Catheter Cardiovasc Interv (2011) 0.89
International Normalized Ratios (INR): the first 20 years. J Thromb Haemost (2004) 0.89
Randomized comparison of radial versus femoral approach for patients with STEMI undergoing early PCI following intravenous thrombolysis. J Invasive Cardiol (2012) 0.89
Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Surg (2006) 0.88
Procoagulant therapeutics in liver disease: a critique and clinical rationale. Nat Rev Gastroenterol Hepatol (2014) 0.85
Low bleeding risk from cardiac catheterization in patients with advanced liver disease. Catheter Cardiovasc Interv (2005) 0.85
The coagulopathy of liver disease: does vitamin K help? Blood Coagul Fibrinolysis (2013) 0.81
The "off-label" role of recombinant factor VIIa in surgery: is the problem deficient evidence or defective concept? J Am Coll Surg (2009) 0.81
Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization. Am J Cardiol (2012) 0.80
Transradial cardiac catheterization in liver transplant candidates. Am J Cardiol (2014) 0.78
Liver biopsy. N Engl J Med (2001) 0.77
Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization. Am J Cardiovasc Dis (2014) 0.77
Vitamin K for upper gastrointestinal bleeding in patients with acute or chronic liver diseases. Cochrane Database Syst Rev (2012) 0.77
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA (2010) 5.06
Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol (2013) 2.99
Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol (2010) 2.83
Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart (2010) 2.42
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension. J Hypertens (2014) 2.28
Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. J Am Coll Cardiol (2010) 1.76
Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines. J Am Coll Cardiol (2011) 1.62
Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation (2010) 1.60
Limitations of the MEDLINE database in constructing meta-analyses. Ann Intern Med (2010) 1.48
Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension (2012) 1.46
The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials. J Hypertens (2014) 1.45
Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes (2014) 1.41
Aspiration thrombectomy in patients undergoing primary angioplasty: totality of data to 2013. Catheter Cardiovasc Interv (2014) 1.33
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med (2010) 1.17
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). J Interv Cardiol (2010) 1.14
Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med (2007) 1.14
Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Am J Med (2009) 1.07
Optical isolation with epsilon-near-zero metamaterials. Opt Express (2013) 1.07
Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J (2011) 1.04
Is clopidogrel cardiovascular medicine's double-edged sword? Circulation (2006) 1.01
Silent ischemia: clinical relevance. J Am Coll Cardiol (2012) 0.99
Effects of enhanced external counterpulsation on arterial stiffness and myocardial oxygen demand in patients with chronic angina pectoris. Am J Cardiol (2011) 0.94
The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials. Am Heart J (2008) 0.91
A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis. Am J Cardiol (2006) 0.89
Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials. Am J Cardiovasc Drugs (2007) 0.89
Fractional flow reserve: an updated review. Clin Cardiol (2014) 0.87
The association between NSAID use and colorectal cancer mortality: results from the women's health initiative. Cancer Epidemiol Biomarkers Prev (2012) 0.86
Flexible integration of high-imaging-resolution and high-power arrays for ultrasound-induced thermal strain imaging (US-TSI). IEEE Trans Ultrason Ferroelectr Freq Control (2013) 0.85
Effect of enhanced external counterpulsation on inflammatory cytokines and adhesion molecules in patients with angina pectoris and angiographic coronary artery disease. Am J Cardiol (2007) 0.85
Protective effects of curcumin, α-lipoic acid, and N-acetylcysteine against carbon tetrachloride-induced liver fibrosis in rats. J Physiol Biochem (2011) 0.85
Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention. Am J Cardiol (2007) 0.85
Outcomes associated with fractional flow-guided revascularization: a meta-analysis. Clin Cardiol (2014) 0.84
Presence of carotid and peripheral arterial disease in patients with left main disease. Am J Cardiol (2007) 0.84
Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting. Ann Thorac Surg (2016) 0.83
Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events. Cleve Clin J Med (2013) 0.83
Mortality risk associated with bundle branch blocks and related repolarization abnormalities (from the Women's Health Initiative [WHI]). Am J Cardiol (2012) 0.83
Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention. Am J Cardiol (2012) 0.82
Does the Baseline Coronary Lesion Length Impact Outcomes With IVUS-Guided Percutaneous Coronary Intervention? J Am Coll Cardiol (2016) 0.82
Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridines. Clin Cardiol (2011) 0.81
Abdominal pain and swelling as an initial presentation of spinal tuberculosis. BMJ Case Rep (2014) 0.80
An adaptive displacement estimation algorithm for improved reconstruction of thermal strain. IEEE Trans Ultrason Ferroelectr Freq Control (2015) 0.80
Acute coronary syndrome (unstable angina and non-ST elevation MI). BMJ Clin Evid (2009) 0.80
The optimal treatment of carotid atherosclerosis: a 2008 update and literature review. Postgrad Med (2008) 0.79
Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents. Am Heart J (2008) 0.79
Drug-eluting stents: dual antiplatelet therapy for every survivor? Circulation (2007) 0.77
Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials. Catheter Cardiovasc Interv (2014) 0.77
Beta-blockers in the management of coronary artery disease: are we on the verge of a new paradigm shift? Recent Pat Cardiovasc Drug Discov (2014) 0.76
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes. Am J Cardiol (2006) 0.76
Images in Cardiovascular Medicine. Don't turn your head! Circulation (2009) 0.75
Routine vs selective invasive strategies in acute coronary syndromes. JAMA (2005) 0.75
Possible benefit to survival from early invasive strategies in patients with acute coronary syndromes. Ann Intern Med (2008) 0.75
Acute myocardial infarction and drug-eluting stents: a green light for their use or time for measured restraint? Am Heart J (2007) 0.75
Designing the ideal risk model for acute coronary syndromes--is simple better than complex? Am Heart J (2007) 0.75
Reply: aspiration thrombectomy: an easily forgiven "latecomer". J Am Coll Cardiol (2014) 0.75
Paving the coronaries with stents: okay in acute coronary syndromes? Clin Cardiol (2011) 0.75
Treatment of hypertension: lower is better, or is it? Hypertension (2012) 0.75
Non ST-elevation acute coronary syndrome. BMJ Clin Evid (2010) 0.75
Understanding and minimizing late thrombosis of drug-eluting stents. Cleve Clin J Med (2007) 0.75
The Risk for Stroke With Aspiration Thrombectomy: Procedure or Patient Related?: Insights From a Meta-Analysis. JACC Cardiovasc Interv (2016) 0.75
Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. Am J Cardiol (2006) 0.75
Postgraduate Education in Quality Improvement Methods: Initial Results of the Fellows' Applied Quality Training (FAQT) Curriculum. Crit Pathw Cardiol (2016) 0.75
Acute myocardial infarction. Am J Med (2005) 0.75
The Hidden Players. JACC Cardiovasc Interv (2016) 0.75
Reply: Mechanical Thrombectomy for Ischemic Stroke. J Am Coll Cardiol (2016) 0.75
Medicare Trends of Takotsubo Cardiomyopathy Outcomes: Is it Just the Tip of an Iceberg? JACC Heart Fail (2016) 0.75
Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials. JACC Cardiovasc Interv (2017) 0.75
Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness. Am Surg (2015) 0.75
Bare metal stent thrombosis 13 years after implantation. Cardiovasc Revasc Med (2009) 0.75
Drug-eluting stents versus bare-metal stents for saphenous vein graft revascularisation: A meta-analysis of randomised trials. EuroIntervention (2017) 0.75
Reply: Meta-Analysis of Strategies for Patients With Multivessel Disease Undergoing Percutaneous Coronary Intervention: Does the Timing of Staged Procedures Matter? JACC Cardiovasc Interv (2017) 0.75
Acute myocardial infarction during infusion of liposomal doxorubicin for recurrent breast cancer. Breast J (2010) 0.75
Clopidogrel and coronary stents: risks and benefits. Curr Atheroscler Rep (2008) 0.75
Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort. J Hypertens (2017) 0.75
Drug-eluting stents: can we move beyond stent thrombosis? Am Heart Hosp J (2007) 0.75
Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Indian Heart J (2009) 0.75